Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabina A Murphy

Showing results (11-20 of 417) with videos related to

Pageof 42
Sort By:
Circulation|December 22, 2025
Linearity in Regression Models: Meaning, Implications, and How to Handle itAndrea Bellavia, Sabina A Murphy
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 25, 2003
Diminution in flow following primary stenting in the INAMI studySabina A Murphy, C Michael Gibson
European Heart Journal|November 28, 2013
Atrial fibrillation and prior MI: searching for balance in ischaemic and bleeding events in patients treated with factor-specific anticoagulantsSabina A Murphy, Robert P Giugliano
The New England Journal of Medicine|July 9, 2005
Intensive lipid lowering with atorvastatin in coronary diseaseChristopher P Cannon, Sabina A Murphy, Eugene Braunwald
Circulation|June 20, 2020
The Safety and Efficacy of Aspirin Discontinuation on a Background of a P2Y<sub>12</sub> Inhibitor in Patients After Percutaneous Coronary Intervention: A Systematic Review and Meta-AnalysisMichelle L O'Donoghue, Sabina A Murphy, Marc S Sabatine
American Heart Journal|January 5, 2002
Mode and timing of treatment failure (recurrent ischemic events) after hospital admission for non-ST segment elevation acute coronary syndromesMarc Cohen, Elliott M Antman, Sabina A Murphy, et al.
European Heart Journal|September 7, 2006
Acute coronary syndromes and diabetes: Is intensive lipid lowering beneficial? Results of the PROVE IT-TIMI 22 trialShaheeda Ahmed, Christopher P Cannon, Sabina A Murphy, et al.
Critical Pathways in Cardiology|December 20, 2007
Evaluation of proton pump inhibitor use in patients with acute coronary syndromes based on risk factors for gastrointestinal bleedGeoffrey C Schreiner, Loren Laine, Sabina A Murphy, et al.
The American Journal of Cardiology|April 26, 2008
A perspective on the efficacy and safety of intensive antiplatelet therapy in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38Stephen D Wiviott, Eugene Braunwald, Sabina A Murphy, et al.
Circulation|November 10, 2010
What is the optimal blood pressure in patients after acute coronary syndromes?: Relationship of blood pressure and cardiovascular events in the PRavastatin OR atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction (PROVE IT-TIMI) 22 trialSripal Bangalore, Jie Qin, Sarah Sloan, et al.
Pageof 42

Showing results (11-20 of 417) with videos related to

Sort By:
Pageof 42
Circulation|December 22, 2025
Linearity in Regression Models: Meaning, Implications, and How to Handle itAndrea Bellavia, Sabina A Murphy
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 25, 2003
Diminution in flow following primary stenting in the INAMI studySabina A Murphy, C Michael Gibson
European Heart Journal|November 28, 2013
Atrial fibrillation and prior MI: searching for balance in ischaemic and bleeding events in patients treated with factor-specific anticoagulantsSabina A Murphy, Robert P Giugliano
The New England Journal of Medicine|July 9, 2005
Intensive lipid lowering with atorvastatin in coronary diseaseChristopher P Cannon, Sabina A Murphy, Eugene Braunwald
Circulation|June 20, 2020
The Safety and Efficacy of Aspirin Discontinuation on a Background of a P2Y<sub>12</sub> Inhibitor in Patients After Percutaneous Coronary Intervention: A Systematic Review and Meta-AnalysisMichelle L O'Donoghue, Sabina A Murphy, Marc S Sabatine
American Heart Journal|January 5, 2002
Mode and timing of treatment failure (recurrent ischemic events) after hospital admission for non-ST segment elevation acute coronary syndromesMarc Cohen, Elliott M Antman, Sabina A Murphy, et al.
European Heart Journal|September 7, 2006
Acute coronary syndromes and diabetes: Is intensive lipid lowering beneficial? Results of the PROVE IT-TIMI 22 trialShaheeda Ahmed, Christopher P Cannon, Sabina A Murphy, et al.
Critical Pathways in Cardiology|December 20, 2007
Evaluation of proton pump inhibitor use in patients with acute coronary syndromes based on risk factors for gastrointestinal bleedGeoffrey C Schreiner, Loren Laine, Sabina A Murphy, et al.
The American Journal of Cardiology|April 26, 2008
A perspective on the efficacy and safety of intensive antiplatelet therapy in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38Stephen D Wiviott, Eugene Braunwald, Sabina A Murphy, et al.
Circulation|November 10, 2010
What is the optimal blood pressure in patients after acute coronary syndromes?: Relationship of blood pressure and cardiovascular events in the PRavastatin OR atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction (PROVE IT-TIMI) 22 trialSripal Bangalore, Jie Qin, Sarah Sloan, et al.
Pageof 42